Allergen immunotherapy extract

3 marketed 1 in Phase 3

This page covers all Allergen immunotherapy extract drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Birch pollen allergens (Bet v 1 and related proteins), Grass pollen allergens (IgE and T-cell epitopes), Grass pollen allergens (Poa pratensis, Lolium perenne, and other grass species).

Targets

Birch pollen allergens (Bet v 1 and related proteins) · Grass pollen allergens (IgE and T-cell epitopes) · Grass pollen allergens (Poa pratensis, Lolium perenne, and other grass species)

Marketed (3)

Phase 3 pipeline (1)